Fingerprint
Dive into the research topics of 'Population pharmacokinetics of the MEK inhibitor selumetinib and its active N-desmethyl metabolite: Data from 10 phase I trials'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Population pharmacokinetics of the MEK inhibitor selumetinib and its active N-desmethyl metabolite: Data from 10 phase I trials
Parul Patel, Eleanor Howgate, Paul Martin, David J. Carlile, Leon Aarons, Diansong Zhou*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
215
Downloads
(Pure)